Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zevra Therapeutics Inc
Total Assets Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Total Assets
$144.4m
CAGR 3-Years
1%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Assets
$178.3B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Assets
$93.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Assets
$216.2B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Assets
$117.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Total Assets
$75.6B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
8%

See Also

What is Zevra Therapeutics Inc's Total Assets?
Total Assets
144.4m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Total Assets amounts to 144.4m USD.

What is Zevra Therapeutics Inc's Total Assets growth rate?
Total Assets CAGR 5Y
62%

Over the last year, the Total Assets growth was 37%. The average annual Total Assets growth rates for Zevra Therapeutics Inc have been 1% over the past three years , 62% over the past five years .

Back to Top